시장조사 보고서 : 세계의 수막구균 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Meningococcal Vaccine Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02087 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 101 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 수막구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (수막염A, 다당류 수막염AC, 수막염ACYW)와 용도별 시장규모 (6개월-15년, 3년 이상, 2년 이상, 3개월 이상) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 수막구균 백신 시장 점유율
- 지역별 수막구균 백신 시장규모
- 주요지역의 종류별 시장규모 (수막염A, 다당류 수막염AC, 수막염ACYW)
- 주요지역의 용도별 시장규모 (6개월-15년, 3년 이상, 2년 이상, 3개월 이상)
- 미주의 수막구균 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 수막구균 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 수막구균 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 수막구균 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 수막구균 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Meningococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 245.5 million in 2020. Over the next five years the Meningococcal Vaccine market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 293.5 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccine Consumption 2016-2026
2.1.2 Meningococcal Vaccine Consumption CAGR by Region
2.2 Meningococcal Vaccine Segment by Type
2.2.1 Meningtits A
2.2.2 Polysaccharide Meningtitis AC
2.2.3 Meningitis ACYW
2.3 Meningococcal Vaccine Sales by Type
2.3.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Meningococcal Vaccine Sale Price by Type (2016-2021)
2.4 Meningococcal Vaccine Segment by Application
2.4.1 6 Months-15Year
2.4.2 over 3 Year
2.4.3 over 2 Year
2.4.4 over 3 Months
2.5 Meningococcal Vaccine Sales by Application
2.5.1 Global Meningococcal Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Meningococcal Vaccine Sale Price by Application (2016-2021)

3 Global Meningococcal Vaccine by Company
3.1 Global Meningococcal Vaccine Sales Market Share by Company
3.1.1 Global Meningococcal Vaccine Sales by Company (2019-2021)
3.1.2 Global Meningococcal Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Meningococcal Vaccine Revenue Market Share by Company
3.2.1 Global Meningococcal Vaccine Revenue by Company (2019-2021)
3.2.2 Global Meningococcal Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Meningococcal Vaccine Sale Price by Company
3.4 Global Manufacturers Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningococcal Vaccine Product Location Distribution
3.4.2 Players Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Meningococcal Vaccine by Region
4.1 Global Meningococcal Vaccine by Region
4.1.1 Global Meningococcal Vaccine Sales by Region
4.1.2 Global Meningococcal Vaccine Revenue by Region
4.2 Americas Meningococcal Vaccine Sales Growth
4.3 APAC Meningococcal Vaccine Sales Growth
4.4 Europe Meningococcal Vaccine Sales Growth
4.5 Middle East & Africa Meningococcal Vaccine Sales Growth

5 Americas
5.1 Americas Meningococcal Vaccine Sales by Country
5.1.1 Americas Meningococcal Vaccine Sales by Country (2016-2021)
5.1.2 Americas Meningococcal Vaccine Revenue by Country (2016-2021)
5.2 Americas Meningococcal Vaccine Sales by Type
5.3 Americas Meningococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Meningococcal Vaccine Sales by Region
6.1.1 APAC Meningococcal Vaccine Sales by Region (2016-2021)
6.1.2 APAC Meningococcal Vaccine Revenue by Region (2016-2021)
6.2 APAC Meningococcal Vaccine Sales by Type
6.3 APAC Meningococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Meningococcal Vaccine by Country
7.1.1 Europe Meningococcal Vaccine Sales by Country (2016-2021)
7.1.2 Europe Meningococcal Vaccine Revenue by Country (2016-2021)
7.2 Europe Meningococcal Vaccine Sales by Type
7.3 Europe Meningococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Vaccine by Country
8.1.1 Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Meningococcal Vaccine Sales by Type
8.3 Middle East & Africa Meningococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Meningococcal Vaccine Distributors
10.3 Meningococcal Vaccine Customer

11 Global Meningococcal Vaccine Market Forecast
11.1 Global Meningococcal Vaccine Forecast by Region
11.1.1 Global Meningococcal Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Meningococcal Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Meningococcal Vaccine Forecast by Type
11.7 Global Meningococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Novartis Company Information
12.1.2 Novartis Meningococcal Vaccine Product Offered
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis Main Business Overview
12.1.5 Novartis Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Meningococcal Vaccine Product Offered
12.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Merck
12.3.1 Merck Company Information
12.3.2 Merck Meningococcal Vaccine Product Offered
12.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Merck Main Business Overview
12.3.5 Merck Latest Developments
12.4 CSL
12.4.1 CSL Company Information
12.4.2 CSL Meningococcal Vaccine Product Offered
12.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 CSL Main Business Overview
12.4.5 CSL Latest Developments
12.5 Baxter
12.5.1 Baxter Company Information
12.5.2 Baxter Meningococcal Vaccine Product Offered
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Baxter Main Business Overview
12.5.5 Baxter Latest Developments
12.6 JN International Medical Corporation
12.6.1 JN International Medical Corporation Company Information
12.6.2 JN International Medical Corporation Meningococcal Vaccine Product Offered
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 JN International Medical Corporation Main Business Overview
12.6.5 JN International Medical Corporation Latest Developments
12.7 Serum Institute of India
12.7.1 Serum Institute of India Company Information
12.7.2 Serum Institute of India Meningococcal Vaccine Product Offered
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Serum Institute of India Main Business Overview
12.7.5 Serum Institute of India Latest Developments
12.8 Bio-Med
12.8.1 Bio-Med Company Information
12.8.2 Bio-Med Meningococcal Vaccine Product Offered
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bio-Med Main Business Overview
12.8.5 Bio-Med Latest Developments
12.9 China National Biotec Group
12.9.1 China National Biotec Group Company Information
12.9.2 China National Biotec Group Meningococcal Vaccine Product Offered
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 China National Biotec Group Main Business Overview
12.9.5 China National Biotec Group Latest Developments
12.10 Hualan Bio
12.10.1 Hualan Bio Company Information
12.10.2 Hualan Bio Meningococcal Vaccine Product Offered
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hualan Bio Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 Walvax
12.11.1 Walvax Company Information
12.11.2 Walvax Meningococcal Vaccine Product Offered
12.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Walvax Main Business Overview
12.11.5 Walvax Latest Developments
12.12 Zhifei
12.12.1 Zhifei Company Information
12.12.2 Zhifei Meningococcal Vaccine Product Offered
12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Zhifei Main Business Overview
12.12.5 Zhifei Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Meningococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Meningtits A
Table 3. Major Players of Polysaccharide Meningtitis AC
Table 4. Major Players of Meningitis ACYW
Table 5. Global Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs)
Table 6. Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Meningococcal Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Meningococcal Vaccine Sale Price by Type (2016-2021)
Table 10. Global Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs)
Table 11. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Meningococcal Vaccine Value by Application (2016-2021)
Table 13. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Meningococcal Vaccine Sale Price by Application (2016-2021)
Table 15. Global Meningococcal Vaccine Sales by Company (2019-2021) & (10K Pcs)
Table 16. Global Meningococcal Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Meningococcal Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Meningococcal Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Meningococcal Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Meningococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Meningococcal Vaccine Products Offered
Table 22. Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meningococcal Vaccine Sales by Region (2016-2021) (10K Pcs)
Table 26. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Meningococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 30. Americas Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs)
Table 34. Americas Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs)
Table 36. Americas Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Meningococcal Vaccine Sales by Region (2016-2021) & (10K Pcs)
Table 38. APAC Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Meningococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs)
Table 42. APAC Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs)
Table 44. APAC Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 46. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs)
Table 50. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs)
Table 52. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 54. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs)
Table 58. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs)
Table 60. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Meningococcal Vaccine
Table 62. Key Application and Potential Industries of Meningococcal Vaccine
Table 63. Key Challenges of Meningococcal Vaccine
Table 64. Key Trends of Meningococcal Vaccine
Table 65. Meningococcal Vaccine Distributors List
Table 66. Meningococcal Vaccine Customer List
Table 67. Global Meningococcal Vaccine Sales Forecast by Region (2021-2026) & (10K Pcs)
Table 68. Global Meningococcal Vaccine Consumption Market Forecast by Region
Table 69. Global Meningococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Meningococcal Vaccine Sales Forecast by Country (2021-2026) & (10K Pcs)
Table 72. Americas Meningococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Meningococcal Vaccine Sales Forecast by Region (2021-2026) & (10K Pcs)
Table 74. APAC Meningococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Meningococcal Vaccine Sales Forecast by Country (2021-2026) & (10K Pcs)
Table 76. Europe Meningococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Meningococcal Vaccine Sales Forecast by Country (2021-2026) & (10K Pcs)
Table 78. Middle East & Africa Meningococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Meningococcal Vaccine Sales Forecast by Type (2021-2026) & (10K Pcs)
Table 80. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Meningococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Meningococcal Vaccine Sales Forecast by Application (2021-2026) & (10K Pcs)
Table 84. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Meningococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 87. Novartis Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Meningococcal Vaccine Product Offered
Table 89. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. GSK Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Meningococcal Vaccine Product Offered
Table 94. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Meningococcal Vaccine Product Offered
Table 99. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. CSL Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Meningococcal Vaccine Product Offered
Table 104. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Baxter Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter Meningococcal Vaccine Product Offered
Table 109. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 110. Baxter Main Business
Table 111. Baxter Latest Developments
Table 112. JN International Medical Corporation Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. JN International Medical Corporation Meningococcal Vaccine Product Offered
Table 114. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 115. JN International Medical Corporation Main Business
Table 116. JN International Medical Corporation Latest Developments
Table 117. Serum Institute of India Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Serum Institute of India Meningococcal Vaccine Product Offered
Table 119. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 120. Serum Institute of India Main Business
Table 121. Serum Institute of India Latest Developments
Table 122. Bio-Med Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Bio-Med Meningococcal Vaccine Product Offered
Table 124. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 125. Bio-Med Main Business
Table 126. Bio-Med Latest Developments
Table 127. China National Biotec Group Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. China National Biotec Group Meningococcal Vaccine Product Offered
Table 129. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 130. China National Biotec Group Main Business
Table 131. China National Biotec Group Latest Developments
Table 132. Hualan Bio Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Bio Meningococcal Vaccine Product Offered
Table 134. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 135. Hualan Bio Main Business
Table 136. Hualan Bio Latest Developments
Table 137. Walvax Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Walvax Meningococcal Vaccine Product Offered
Table 139. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 140. Walvax Main Business
Table 141. Walvax Latest Developments
Table 142. Zhifei Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Zhifei Meningococcal Vaccine Product Offered
Table 144. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 145. Zhifei Main Business
Table 146. Zhifei Latest Developments
List of Figures
Figure 1. Picture of Meningococcal Vaccine
Figure 2. Meningococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Vaccine Sales Growth Rate 2016-2026 (10K Pcs)
Figure 7. Global Meningococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Meningococcal Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Meningtits A
Figure 10. Product Picture of Polysaccharide Meningtitis AC
Figure 11. Product Picture of Meningitis ACYW
Figure 12. Global Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 13. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Meningococcal Vaccine Consumed in 6 Months-15Year
Figure 15. Global Meningococcal Vaccine Market: 6 Months-15Year (2016-2021) & (10K Pcs)
Figure 16. Meningococcal Vaccine Consumed in over 3 Year
Figure 17. Global Meningococcal Vaccine Market: over 3 Year (2016-2021) & (10K Pcs)
Figure 18. Meningococcal Vaccine Consumed in over 2 Year
Figure 19. Global Meningococcal Vaccine Market: over 2 Year (2016-2021) & (10K Pcs)
Figure 20. Meningococcal Vaccine Consumed in over 3 Months
Figure 21. Global Meningococcal Vaccine Market: over 3 Months (2016-2021) & (10K Pcs)
Figure 22. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Figure 23. Global Meningococcal Vaccine Revenue Market Share by Application in 2020
Figure 24. Meningococcal Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Meningococcal Vaccine Revenue Market Share by Company in 2020
Figure 26. Global Meningococcal Vaccine Sales Market Share by Regions (2016-2021)
Figure 27. Global Meningococcal Vaccine Revenue Market Share by Region in 2020
Figure 28. Americas Meningococcal Vaccine Sales 2016-2021 (10K Pcs)
Figure 29. Americas Meningococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. APAC Meningococcal Vaccine Sales 2016-2021 (10K Pcs)
Figure 31. APAC Meningococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Europe Meningococcal Vaccine Sales 2016-2021 (10K Pcs)
Figure 33. Europe Meningococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Meningococcal Vaccine Sales 2016-2021 (10K Pcs)
Figure 35. Middle East & Africa Meningococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 36. Americas Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 37. Americas Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 38. Americas Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 39. Americas Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 40. United States Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Meningococcal Vaccine Sales Market Share by Region in 2020
Figure 45. APAC Meningococcal Vaccine Revenue Market Share by Regions in 2020
Figure 46. APAC Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 47. APAC Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 48. China Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 55. Europe Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 56. Europe Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 57. Europe Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 58. Germany Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 67. Egypt Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles

※본 조사보고서 [세계의 수막구균 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02087) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 수막구균 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 폐렴구균 백신 시장예측 2021년-2026년
LPI-2201K02154 / LP Information / 2021년 12월 / 본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 종양 세포 백신 시장예측 2021년-2026년
LPI-2201K02666 / LP Information / 2021년 12월 / 본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년
LPI-2201K02170 / LP Information / 2021년 12월 / 본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 수두 백신 시장예측 2021년-2026년
LPI-2201K02212 / LP Information / 2021년 12월 / 본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over...

세계의 백신 투여 시장예측 2021년-2026년
LPI-2201K02327 / LP Information / 2021년 12월 / 본 조사보고서는 백신 투여의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Vaccine Administration will have significant change from previous year. By the most conservative estimates of global Vaccine Administration market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...